Actively Recruiting
Evaluation of NeoRetina Artificial Intelligence Algorithm for the Screening of Diabetic Retinopathy at the CHUM
Led by Centre hospitalier de l'Université de Montréal (CHUM) · Updated on 2024-09-19
630
Participants Needed
1
Research Sites
129 weeks
Total Duration
On this page
Sponsors
C
Centre hospitalier de l'Université de Montréal (CHUM)
Lead Sponsor
D
DIAGNOS Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
This prospective study aims to validate if NeoRetina, an artificial intelligence algorithm developped by DIAGNOS Inc. and trained to automatically detect the presence of diabetic retinopathy (DR) by the analysis of macula centered eye fundus photographies, can detect this disease and grade its severity.
CONDITIONS
Official Title
Evaluation of NeoRetina Artificial Intelligence Algorithm for the Screening of Diabetic Retinopathy at the CHUM
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients 18 years old and older
- Ability to provide informed consent
- Diagnosis of diabetes: type 1 diabetes for at least 5 years or type 2 diabetes
- Diabetic patient followed or referred by a CHUM physician, including endocrinologist follow-up, hospitalization at CHUM, or on the Ophthalmology Clinic waiting list for DR evaluation
You will not qualify if you...
- Patients younger than 18 years old
- Inability to provide informed consent
- Previous treatment (surgery, laser, injection, etc.) for any retinal condition such as age-related macular degeneration or retinal vascular occlusion
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre hospitalier de l'Université de Montréal
Montreal, Quebec, Canada, H2X 0A9
Actively Recruiting
Research Team
M
Marie-Catherine Tessier, MSc
CONTACT
K
Karim Hammamji, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here